KALA BIO, Inc. (KALA) Analyst Estimates Annual - Discounting Cash Flows
KALA
KALA BIO, Inc.
KALA (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
2019
12-30
Number of Analysts 1 1 1 1 1 2 3 1 1 2 1
Estimated Revenue
Low 229.3 134.2 26.12 25 41.35 3.33 1.67 3.76 12.58 6.43 7.77
Average 229.3 134.2 26.12 25 41.35 3.33 1.67 3.76 12.58 6.43 7.77
High 229.3 134.2 26.12 25 41.35 3.33 1.67 3.76 12.58 6.43 7.77
Estimated EBITDA
Low -45.87 -26.85 -5.22 -5 -8.27 -0.667 -133.2 -121.4 -2.52 -100.9 -101.6
Average -45.87 -26.85 -5.22 -5 -8.27 -0.667 -111 -101.1 -2.52 -84.06 -84.64
High -45.87 -26.85 -5.22 -5 -8.27 -0.667 -88.83 -80.9 -2.52 -67.25 -67.71
Estimated EBIT
Low -45.87 -26.85 -5.22 -5 -8.27 -0.667 -130.1 -117.8 -2.52 -102.4 -105.4
Average -45.87 -26.85 -5.22 -5 -8.27 -0.667 -108.4 -98.17 -2.52 -85.33 -87.81
High -45.87 -26.85 -5.22 -5 -8.27 -0.667 -86.72 -78.54 -2.52 -68.27 -70.25
Estimated Net Income
Low -0.938 -0.994 -2.21 -2.93 -24.57 -61.08 -46.46 -131 -485.2 -111.1 -112.7
Average -0.938 -0.994 -2.21 -2.93 -24.57 -59.78 -38.72 -109.1 -485.2 -92.57 -93.88
High -0.938 -0.994 -2.21 -2.93 -24.57 -58.49 -30.97 -87.31 -485.2 -74.05 -75.11
Estimated SGA Expenses
Low 1,871 1,095 213.1 204 337.4 27.2 13.6 30.69 102.7 52.45 63.44
Average 1,871 1,095 213.1 204 337.4 27.2 13.6 30.69 102.7 52.45 63.44
High 1,871 1,095 213.1 204 337.4 27.2 13.6 30.69 102.7 52.45 63.44
Estimated EPS
Low -0.17 -0.18 -0.4 -0.53 -4.45 -11.06 -18.03 -23.79 -87.9 -92.29 -134
Average -0.17 -0.18 -0.4 -0.53 -4.45 -10.84 -18.03 -23.79 -87.9 -92.29 -134
High -0.17 -0.18 -0.4 -0.53 -4.45 -10.6 -18.03 -23.79 -87.9 -92.29 -134
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program